Testing effectiveness (Phase 2)Study completedNCT02588586What this trial is testingThe Safety and Antiretroviral Activity of 3BNC117Who this might be right forHIV-1 Infection Rockefeller University 17
Not applicableStudy completedNCT00000922What this trial is testingEvaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Early research (Phase 1)Study completedNCT00006495What this trial is testingImmune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableStudy completedNCT02384395What this trial is testingSafety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV InfectionWho this might be right forHIVAcute HIV Infection University of North Carolina, Chapel Hill 40
Not applicableStudy completedNCT00001075What this trial is testingThe Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 55
Post-approval studies (Phase 4)Study completedNCT00931463What this trial is testingA Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line RegimenWho this might be right forHIV Infections Kirby Institute 558
Large-scale testing (Phase 3)Study completedNCT00006154What this trial is testingEvaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV InfectionWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 165
Testing effectiveness (Phase 2)Study completedNCT00005001What this trial is testingSafety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)Who this might be right forHIV Infections Agouron Pharmaceuticals 40
Testing effectiveness (Phase 2)Looking for participantsNCT07202546What this trial is testingA Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)Who this might be right forHIV Infections ViiV Healthcare 186
Testing effectiveness (Phase 2)Study completedNCT00454181What this trial is testingTreatment of Oral Warts in HIV+ PatientsWho this might be right forPapillomatosisHIV Infections Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 59
Not applicableStudy completedNCT00000732What this trial is testingEvaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and ZidovudineWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00799136What this trial is testingA Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARLWho this might be right forLymphoma, AIDS RelatedHIV Infections Ontario Clinical Oncology Group (OCOG) 6
Early research (Phase 1)Study completedNCT00000899What this trial is testingA Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT00002299What this trial is testingThe Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSWho this might be right forCytomegalovirus RetinitisHIV Infections Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00389207What this trial is testingNevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive AdultsWho this might be right forHIV Infections Boehringer Ingelheim 576
Large-scale testing (Phase 3)Study completedNCT01348308What this trial is testingImmuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected PatientsWho this might be right forHIV-1 InfectionAIDS ANRS, Emerging Infectious Diseases 407
Not applicableStudy completedNCT01976715What this trial is testingStudy of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral TherapyWho this might be right forAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAIDS Virus+2 more National Institute of Allergy and Infectious Diseases (NIAID) 26
Not applicableStudy completedNCT00002285What this trial is testingZidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDSWho this might be right forHIV Infections Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00672412What this trial is testingSafety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT05850728What this trial is testingFirst in Human Study of TLC-ART 101 (ACTU 2001)Who this might be right forHuman Immunodeficiency VirusTreatmentAntiretroviral Therapy University of Washington 12